ACCESS Announces Multi-Year Strategic Agreement to Bring Advanced Cardiac Electrophysiology Technologies to Ambulatory Surgery Centers
Agreement supports ACCESS-affiliated ASCs in adopting the CARTO™ System and its integrated portfolio of mapping, intracardiac imaging, radiofrequency ablation and pulsed field ablation technologies
ACCESS, through its physician-led group purchasing organization, ACCESS GPO, today announced a multi-year preferred portfolio agreement with Johnson & Johnson to support the adoption of advanced cardiac electrophysiology technologies in ambulatory surgery centers (ASC) across the United States. The agreement encompasses an integrated portfolio of three-dimensional mapping, intracardiac imaging, radiofrequency ablation and pulsed field ablation technologies.
The collaboration is designed to help ASCs expand access to state-of-the-art therapies for the treatment of cardiac arrhythmias while supporting the continued evolution of cardiac electrophysiology care in the outpatient setting. As the demand for catheter ablation continues to grow nationwide, ASCs are expected to play an increasingly important role in expanding procedural capacity, improving patient access, and delivering high-quality care in a cost-effective environment. The agreement broadens the technology options available to ACCESS-affiliated centers and supports the continued development of high-quality electrophysiology programs in appropriately equipped outpatient settings.
